Journal of Immune Based Therapies, Vaccines and Antimicrobials
Vol.4 No.1(2015), Paper ID 53325, 8
pages
DOI:10.4236/jibtva.2015.41001
Comparative Clinical Trial of Antibodies to Interferon-Gamma (IFN-γ) and Tumor Necrosis Factor-Alpha (TNF-α) in the Treatment of Rheumatoid Arthritis
Simon Skurkovich, Galina Lukina, Yakov Sigidin, Olga Pushkova, Evelyna Mach, Boris Skurkovich
Advanced Biotherapy Laboratories, Rockville, USA
Institute of Rheumatology, Russian Academy of Medical Sciences, Moscow, Russia
Institute of Rheumatology, Russian Academy of Medical Sciences, Moscow, Russia
Institute of Rheumatology, Russian Academy of Medical Sciences, Moscow, Russia
Institute of Rheumatology, Russian Academy of Medical Sciences, Moscow, Russia
Warren Alpert Medical School of Brown University, Providence, USA
Copyright © 2015 Simon Skurkovich, Galina Lukina, Yakov Sigidin, Olga Pushkova, Evelyna Mach, Boris Skurkovich et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Skurkovich, S. , Lukina, G. , Sigidin, Y. , Pushkova, O. , Mach, E. and Skurkovich, B. (2015) Comparative Clinical Trial of Antibodies to Interferon-Gamma (IFN-γ) and Tumor Necrosis Factor-Alpha (TNF-α) in the Treatment of Rheumatoid Arthritis.
Journal of Immune Based Therapies, Vaccines and Antimicrobials,
4, 1-8. doi:
10.4236/jibtva.2015.41001.